A Multi-Institutional Analysis of the Socioeconomic Determinants of Breast Reconstruction

Christian, Caprice K.; Niland, Joyce C.; Edge, Stephen B.; Ottesen, Rebecca A.; Hughes, Melissa E.; Theriault, Richard L.; Wilson, John L.; Hergrueter, Charles A.; Weeks, Jane C.

doi:10.1097/01.sla.0000197738.63512.23

Cited by 194 publications

(150 citation statements)

References 34 publications

Supporting

Mentioning

133

Contrasting

Unclassified

Order By: Relevance

“…This compares favourably with rates of 16–59 per cent internationally3 8, 19 27, 28, 29, 30. The strongest predictors of PMBR cited were: age under 50 years; white race; higher income and education; and earlier disease stage31.…”

Section: Discussionmentioning

confidence: 75%

Trends in breast reconstruction practices in a specialized breast tertiary referral centre

et al. 2017

View full text Add to dashboard Cite

BackgroundBreast reconstruction is an important component of multidisciplinary breast cancer management. The practice of breast reconstruction after mastectomy has evolved significantly in the past decade as a result of both increasing mastectomy rates and advances in reconstructive strategy. These changes have significantly influenced the contemporary surgical management of breast cancer. The aim of this study was to examine trends in breast reconstruction after mastectomy in an Irish population.MethodsData were reviewed from a database of all patients who had mastectomy with or without breast reconstruction at Galway University Hospital, a tertiary breast cancer referral centre, between 2004 and 2014. Trends in breast reconstruction after mastectomy were explored with respect to patient demographics, clinicopathological features, and neoadjuvant and adjuvant therapy.ResultsOf 1303 patients who underwent mastectomy during interval studied, 706 (54.2 per cent) had breast reconstruction after mastectomy. In 629 patients (89·1 per cent), breast reconstruction was performed in the immediate setting. Reconstruction rates increased over time from 20·5 per cent in 2004 to 44·7 per cent in 2014. Reconstruction was more commonly performed in younger patients and those with benign, in situ and early‐stage disease. A negative relationship between radiotherapy and reconstruction was observed. A pedicled flap with or without an implant was the most commonly used reconstructive approach in patients receiving radiotherapy.ConclusionBreast reconstruction after mastectomy has become the standard of care in the surgical treatment of breast cancer. Recent trends show a transition favouring implant‐based approaches.

show abstract

Section: Discussionmentioning

confidence: 75%

Trends in breast reconstruction practices in a specialized breast tertiary referral centre

et al. 2017

View full text Add to dashboard Cite

show abstract

“…The eligibility criteria and data collection procedures for the database were described previously [17][18][19]. Briefly, clinical, treatment, and recurrence information is abstracted from medical records by dedicated and trained clinical research associates at each site.…”

Section: Data Sourcementioning

confidence: 99%

Continued Use of Trastuzumab Beyond Disease Progression in the National Comprehensive Cancer Network: Should We Practice Ahead of the Evidence?

et al. 2011

Self Cite

View full text Add to dashboard Cite

Background. The role of continued trastuzumab after progression in women with human epidermal growth factor receptor (HER)-2 ؉ metastatic breast cancer is controversial. Controlled clinical trials that establish a benefit from continued trastuzumab have been difficult to complete.Methods. In the National Comprehensive Cancer Center Network (NCCN) Breast Cancer Outcomes Database, we identified women treated with trastuzumab for metastatic or relapsed HER-2 ؉ breast cancer at eight NCCN centers who subsequently progressed. Patients were eligible for this analysis if they initiated treatment at an NCCN institution between July 1997 and December 2004, received trastuzumab-containing treatment, and progressed while on therapy. We calculated the proportion of patients who received trastuzumab after progression, and in a multivariate analysis assessed the association of pa-

show abstract

“…As with many other high-cost elective procedures, previous studies have demonstrated racial and socioeconomic variations in the utilization of post-mastectomy reconstruction. [1][2][3][4][5][6][7][8][9][10] Careful review of these studies suggests that the observed racial disparities likely reflect differences in socioeconomic status. In fact, the majority of studies that account for differences in individual SES find that race is not a significant predictor of reconstruction.…”

Section: Introductionmentioning

confidence: 99%

Do Variations in Provider Discussions Explain Socioeconomic Disparities in Postmastectomy Breast Reconstruction?

Greenberg

Schneider

Lipsitz

et al. 2008

Journal of the American College of Surgeons

Self Cite

View full text Add to dashboard Cite

show abstract

A Multi-Institutional Analysis of the Socioeconomic Determinants of Breast Reconstruction

Cited by 194 publications

References 34 publications

Trends in breast reconstruction practices in a specialized breast tertiary referral centre

Trends in breast reconstruction practices in a specialized breast tertiary referral centre

Continued Use of Trastuzumab Beyond Disease Progression in the National Comprehensive Cancer Network: Should We Practice Ahead of the Evidence?

Do Variations in Provider Discussions Explain Socioeconomic Disparities in Postmastectomy Breast Reconstruction?

Contact Info

Product

Resources

About